Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 May;17(5):623-625.
doi: 10.2215/CJN.03410322. Epub 2022 Apr 25.

Treatment Options for Venous Thromboembolism in Patients Receiving Dialysis

Thomas A Mavrakanas  1
Affiliations
Editorial

Treatment Options for Venous Thromboembolism in Patients Receiving Dialysis

Thomas A Mavrakanas. Clin J Am Soc Nephrol. 2022 May.
No abstract available

Keywords: apixaban; dialysis; major bleeding; venous thromboembolism; warfarin.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Conventional and apixaban-based management of venous thromboembolic disease in patients with preserved kidney function or moderate CKD (creatinine clearance ≥25 ml/min and creatinine ≤2.5 mg/dl). bid, twice daily; INR, international normalized ratio; VKA, vitamin K antagonist. *In selected patients at high risk of recurrence; †if there is clinical equipoise about continuation or cessation of anticoagulation.
See this image and copyright information in PMC

Comment on

References

    1. Wattanakit K, Cushman M, Stehman-Breen C, Heckbert SR, Folsom AR: Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol 19: 135–140, 2008 - PMC - PubMed
    1. Kumar G, Sakhuja A, Taneja A, Majumdar T, Patel J, Whittle J, Nanchal R; Milwaukee Initiative in Critical Care Outcomes Research (MICCOR) Group of Investigators : Pulmonary embolism in patients with CKD and ESRD. Clin J Am Soc Nephrol 7: 1584–1590, 2012 - PMC - PubMed
    1. Goto S, Haas S, Ageno W, Goldhaber SZ, Turpie AGG, Weitz JI, Angchaisuksiri P, Nielsen JD, Kayani G, Farjat A, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE Investigators : Assessment of outcomes among patients with venous thromboembolism with and without chronic kidney disease. JAMA Netw Open 3: e2022886, 2020 - PMC - PubMed
    1. Mavrakanas T, Bounameaux H: The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism. Pharmacol Ther 130: 46–58, 2011 - PubMed
    1. Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI; AMPLIFY Investigators : Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 369: 799–808, 2013 - PubMed